Sharemaestro Newsreel

Qiagen (QGEN) Stock Faces An Execution Puzzle After Margin Rebound

Natera (NTRA) Posted Strong Q2 Results, Is The Stock Fully Priced?

GRAIL (GRAL) Stock Sinks As Cash Burn Drowns Galleri Growth

Thermo Fisher Scientific Inc. (TMO.TO) Stock Price, News, Quote & History

This article provides a detailed stock overview for Thermo Fisher Scientific Inc. (TMO.TO), showing its current stock price, recent performance metrics across various timeframes, and key financial data. It also lists related tickers and other companies people are watching, alongside general market information.

FMR LLC (ICLR) discloses 6.9% ICON PLC stake for Abigail P. Johnson

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 6.9% of ICON PLC's common stock, totaling 5,271,320.61 shares. Abigail P. Johnson is also reported as a beneficial owner of these same shares, holding sole dispositive power but no voting power. …

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

NeoGenomics (NEO) reported a return to profitability in Q2 2026 with US$2.24 million net income and raised its full-year 2026 revenue outlook to US$802 million–US$806 million, indicating improving operational performance. This positive shift strengthens the company's investment narrative, emphasizing its role as a specialized …

Waters Corp (WAZ.DU) Analyst insights, Price targets and Recommendations

This article provides analyst insights, price targets, and recommendations for Waters Corp (WAZ.DU), highlighting recent upgrades and downgrades from various financial institutions. It shows that TD Cowen upgraded the stock from Hold to Buy, while other firms like RBC Capital, Evercore ISI Group, Wells …

Charles River Benefits From an Improving Demand Environment Despite No Moat

Charles River Laboratories, a company specializing in animal research models and drug development services, is experiencing an improving demand environment, leading to a stronger near-term outlook. Despite not having an economic moat, the company's business strategy, which serves nearly all top biopharma players, is …

NeoGenomics, Inc. Revenue Breakdown – BX:NG9

NeoGenomics, Inc. (BX:NG9) generated 576.61 million CHF in revenue last year. The "Client Direct Billing" segment was the top performer, contributing 411.32 million CHF, a decrease from the previous year. The United States was the primary regional contributor, accounting for all of the company's …

Natera Inc (NTRA) (Q2 2026) Earnings Call Highlights: Record Volumes and Raised Guidance Signal ...

Natera Inc. (NTRA) reported record Q2 2026 results, including approximately $753 million in total revenue and 1,044,000 tests processed, leading to a raised revenue guidance for fiscal 2026. The company highlighted significant growth in oncology volumes, improved gross margins, and strategic advancements in its …

Charles River Laboratories International (NYSE:CRL) Upgraded by JPMorgan Chase & Co. to "Overweight" Rating

JPMorgan Chase & Co. upgraded Charles River Laboratories International (NYSE:CRL) to an "overweight" rating from "neutral" and significantly raised its price target to $310 from $180, suggesting a 19.18% upside. This upgrade follows Charles River's strong second-quarter performance, where it surpassed EPS and revenue …

Charles River Laboratories (NYSE: CRL) insider plans Rule 144 sale of RSU and option shares

An insider at Charles River Laboratories (NYSE: CRL) plans to sell 4,300 shares from Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) granted in 2022, along with 2,345 shares from a stock option exercise. The anticipated sale date is August 6, 2026, with …

Guardant Health co-CEO Helmy Eltoukhy sells $12.6m in stock

Guardant Health co-CEO Helmy Eltoukhy sold approximately $12.6 million worth of common stock on June 5, 2026, through his revocable trust. The sale involved 90,000 shares at prices ranging from $125.569 to $132.55, occurring as the stock trades near its 52-week high after a …

Natera Inc earnings beat by $0.02, revenue topped estimates

Natera Inc (NASDAQ: NTRA) reported strong second-quarter results, beating analyst EPS estimates by $0.0

CareDx, Inc. (CDNA) insider sells 2,688 shares under trading plan

CareDx, Inc. Secretary and General Counsel Jeffrey Adam Novack sold 2,688 shares of common stock on August 5, 2026, under a Rule 10b5-1 trading plan established in September 2025. The sales were executed in two tranches at weighted average prices of $46.1492 and $46.75 …

ETFs Investing in Mettler-Toledo International Inc. Stocks

This article lists various ETFs that include Mettler-Toledo International Inc. (MTO) stocks in their portfolios, offering investors diversified exposure to the company. The list provides key details for each ETF, such as market value, weight of MTO in the fund, issuer, management style, expense …

XWELL, Inc. Announces Board and Committee Changes, Effective August 8, 2026

XWELL, Inc. announced board and committee changes effective August 3, 2026. Ezra T. Ernst resigned from the board to focus on his CEO and President responsibilities, while Gerard Reid was appointed as a new director. Reid brings extensive experience in energy transition, technology, and …

Dimensional Fund Advisors LP Has $25.38 Million Stock Position in CareDx, Inc. $CDNA

Dimensional Fund Advisors LP significantly increased its stake in CareDx, Inc. by 11.6% in the first quarter, now holding 1.46 million shares valued at $25.38 million. This comes as CareDx reported stronger-than-expected quarterly earnings and revenue. Despite mixed analyst ratings and recent insider stock …

Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 20,356 Shares of Stock

Castle Biosciences insider Derek Maetzold sold 20,356 shares of the company's stock for over $633,000, reducing his ownership by nearly half. This sale was executed under a pre-arranged Rule 10b5-1 trading plan. The company recently reported better-than-expected quarterly results, and analysts maintain a "Moderate …

Biodesix, Inc. Stock 12‑Month Price Target Raised to $32.67, Implies 43% Upside

Biodesix, Inc. (BDSX) has seen its average 12-month price target increased by analysts from $30.83 to $32.67, suggesting a potential 43% upside based on the Aug. 5 closing price. The consensus rating from 7 analysts remains a "Buy," with all seven recommending the stock.

Tobin Juvenal Sells 1,301 Shares of Castle Biosciences (NASDAQ:CSTL) Stock

Tobin Juvenal, an insider at Castle Biosciences (NASDAQ:CSTL), sold 1,301 shares of the company's stock for approximately $49,945, reducing his position by 1.65%. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan. Despite insider sales, Castle Biosciences' recent quarterly results exceeded …

Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test

Agilent Technologies (NYSE:A) has received expanded European approval for its PD-L1 IHC 22C3 pharmDx test, now covering ovarian, fallopian tube, and primary peritoneal carcinoma in the EU. This approval broadens the application of the test for patients eligible for Merck's Keytruda and reinforces Agilent's …

Natera (NTRA) Reports Q2 Loss, Beats Revenue Estimates

Sotera Health Co (SHC) Shares Surge 5.1% -- What GF Score of 77 Tells Investors

NATERA ($NTRA) Releases Q2 2026 Earnings, Stock Rises

Earnings call transcript: Natera tops revenue view in Q2 2026, shares jump after hours

Natera, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NTRA)

Natera, Inc. (NTRA) released its Q2 2026 earnings, reporting an EPS of -$0.47, which beat estimates by $0.06. The company's revenue for the quarter reached $752.75 million, surpassing expectations by $91.46 million and representing a 37.71% year-over-year increase. This article includes the slide deck …

Guardant Health director Manuel Hidalgo Medina sells $279k in stock

Guardant Health director Manuel Hidalgo Medina recently sold approximately $279,201 worth of stock, while also acquiring shares valued at $30,922 through stock options. These transactions occurred as the company's stock trades near its 52-week high, having seen a 266% return over the past year. …

Twist Bioscience Corporation (NASDAQ:TWST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Twist Bioscience Corporation (NASDAQ:TWST) has received a "Moderate Buy" consensus recommendation from brokerages, with eight buy ratings, one hold, and one sell among ten analysts. Despite an average 12-month price target of $98.30, below its recent opening price of $115.01, the company reported strong …

Danaher Corp (NYSE: DHR) grants 41,072 RSUs to Executive VP Riley

Danaher Corporation granted Executive Vice President Christopher Paul Riley 41,072 restricted stock units (RSUs) as part of its Long-Term Growth Program. These RSUs, payable solely in common stock, will vest in two tranches: 50% on the 18-month anniversary and 50% on the 30-month anniversary …

Danaher Corp (NYSE: DHR) awards 92,138 stock options to Chief Legal Officer

Danaher Corporation (NYSE: DHR) has awarded its SVP-Chief Legal Officer, Jonathan Leiken, 92,138 employee stock options. These options, part of the company's Long-Term Growth Program, have an exercise price of $194.78 per share and expire on August 4, 2036. The options will vest in …

Medpace Holdings (MEDP) Updates 2026 Guidance, Is The Upside Already Priced In?

Illumina (ILMN) sees Corvex-advised funds sell 741,127 common shares

Illumina director Keith A. Meister reported that private investment funds advised by Corvex Management LP sold 741,127 shares of Illumina common stock between August 4-5, 2026. The sales occurred in multiple transactions at weighted-average prices ranging from $196.74 to $203.28 per share. This transaction …

Check-Cap Ltd. (NASDAQ: MBAI) expands MBody AI into outdoor robot services

Check-Cap Ltd. announced that its merger partner, MBody AI Corp., is expanding its autonomous services from indoor to outdoor applications. MBody AI has secured exclusive U.S. distribution rights for outdoor cleaning robots across six states for gaming and large hotel operators and has already …

ICON plc (NASDAQ: ICLR) prices $2.15B notes to refinance secured debt

ICON plc announced the pricing of $2.15 billion in senior unsecured notes through its subsidiary, ICON Investments Six DAC, to refinance existing secured debt. The offering, consisting of three tranches due in 2029, 2031, and 2036, is expected to close on August 13, 2026. …

CareDx, Inc. (CDNA) director sells 16,000 shares in planned trade

CareDx, Inc. director Christine Cournoyer sold 16,000 shares of common stock on August 4, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $46.9358 per share, ranging from $46.25 to $47.2250, leaving her with 42,943 shares. …